Timely by DrFirst

Overview

Timely by DrFirst is DrFirst’s EHR-embedded pharma patient-access and engagement platform, built on a medication-management network that reaches 450K+ prescribers and 270+ EHRs. It supports brand-management, market-access, and patient-support teams across the medication journey: brand awareness at prescribing, copay support, electronic prior authorization, hub enrollment, specialty-pharmacy selection, and adherence messaging.

Timely is not a full operating hub: it does not run noncommercial pharmacy, 3PL, or human case-management. It is the EHR-embedded layer manufacturers run alongside a hub to compress time from prescription to therapy through point-of-prescribing patient engagement. DrFirst’s 2024 Myndshft acquisition adds medical-benefit PA depth, and implementation staffing should be evaluated across both the Timely product team and broader DrFirst organization.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Timely by DrFirst is evaluated as an EHR-embedded patient-access and engagement layer that runs alongside a hub.

Capability	Buyer should compare	Timely by DrFirst readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	EHR enrollment trigger. Hub program enrollment is initiated inside the EHR workflow; confirm handoff to the manufacturer’s hub of record.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Coverage workflow. Myndshft adds medical-benefit verification alongside pharmacy benefits; confirm payer-rule coverage.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Prescribing-workflow PA. Electronic prior authorization is embedded in prescribing workflow; Myndshft adds medical-benefit PA.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Point-of-prescribing support. EHR-embedded brand info and copay support are delivered before the patient leaves the prescribing workflow.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Provider-sourced outreach. Timely reports <1% opt-out, 85% engagement, and up to 10% fill lift; validate by brand and therapy.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Routing only. Specialty pharmacy selection is supported at prescribing; no owned dispensing or 3PL.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Reporting layer. Reporting is built on EHR engagement and ePA data; HITRUST i1 certified across DrFirst’s medication-management portfolio (March 2025).

Buyer Fit

• Primary buying context: Include Timely when a launch needs point-of-prescribing engagement — brand awareness, copay, ePA, hub enrollment — embedded in the EHR workflow rather than delivered through a separate channel after the script is written.
• Best-fit buyers: Pharma manufacturers and biotech launch teams with specialty and biologic brands prescribed through office-based providers using major EHRs.
• Less ideal fit: Programs that need a full reimbursement-and-PA hub, owned specialty pharmacy or 3PL, or rare-disease patient services with intensive white-glove case management.
• Commercial fit: Custom/RFP; expect program-level pricing tied to prescriber reach, brand-specific engagement modules, and ePA volume.
• Decision checks: Confirm EHR coverage for your target prescriber footprint, opt-out, fill-lift, and engagement metrics by therapy class, Myndshft medical-benefit PA depth, implementation staffing across Timely and DrFirst, and data-feed integration with your hub of record.

Differentiators

• DrFirst network reach: Timely sits on DrFirst’s medication-management footprint across 450K+ prescribers, 270+ EHRs, and a large pharmacy network.
• Company-reported pharma adoption: Timely says 17 of the top 20 pharmaceutical companies use the platform; ask for brand-level scope, active modules, and prescriber reach.
• Company-reported engagement metrics: Timely cites 85% patient engagement, up to 10% fill lift, and <1% opt-out; treat these as RFP proof points until customer-level methodology is provided.
• EHR-embedded brand, copay, and hub enrollment: Engagement happens at the point of prescribing rather than after the patient leaves the office.
• Buyer-segment packaging: Current Timely materials segment the product for brand management, market access, and patient support teams rather than only adherence marketing.
• Myndshft medical-benefit PA (2024 acquisition): Adds buy-and-bill PA depth to DrFirst’s pharmacy-benefit ePA foundation.
• HITRUST i1 certified: Achieved March 2025 across DrFirst’s medication-management portfolio, including patient engagement and ePA.

RFP Questions

• Which EHRs and prescriber specialties are live for your target therapy class today?
• How does Timely hand off enrolled patients to a manufacturer’s hub of record?
• What opt-out and engagement metrics are reported by brand, geography, and EHR?
• How are company-reported fill-lift metrics calculated, and what control group or baseline is used?
• How does the Myndshft medical-benefit PA capability work in practice for buy-and-bill products?
• What manufacturer dashboards are available, and how is reporting reconciled against the hub system of record?
• How are MLR, pharmacovigilance, adverse-event, and product-quality complaints handled inside EHR-embedded engagement?
• How is consent captured and managed when patient messaging is sourced from the prescriber rather than the manufacturer?
• Which implementation and support roles are staffed by the Timely product team versus the broader DrFirst organization?

Recent Activity

• 2026: Current Timely positioning is organized around brand-management, market-access, and patient-support teams, with company-reported 17-of-top-20 pharma adoption plus 85% engagement, up-to-10% fill lift, and <1% opt-out metrics.
• 2025-08: Humana and DrFirst expanded care-gap closure program for chronic conditions.
• 2025-03: HITRUST i1 certification achieved across DrFirst’s medication-management portfolio, including Timely.
• 2024: DrFirst acquired Myndshft, adding medical-benefit prior authorization to its pharmacy-benefit ePA platform.
• 2020-21: $135M equity investment closed (Sixth Street Growth) supporting DrFirst’s medication-management expansion.